Fort Washington Investment Advisors Inc. OH Sells 34,670 Shares of Doximity, Inc. (NASDAQ:DOCS)

Fort Washington Investment Advisors Inc. OH trimmed its stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 14.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 213,330 shares of the company's stock after selling 34,670 shares during the quarter. Fort Washington Investment Advisors Inc. OH owned approximately 0.11% of Doximity worth $12,380,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of DOCS. Global Retirement Partners LLC grew its position in Doximity by 468.1% during the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock worth $29,000 after acquiring an additional 440 shares during the last quarter. Larson Financial Group LLC grew its position in shares of Doximity by 49.4% in the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company's stock worth $40,000 after buying an additional 250 shares during the last quarter. Optimum Investment Advisors bought a new stake in shares of Doximity in the 4th quarter worth approximately $43,000. Kapitalo Investimentos Ltda bought a new stake in shares of Doximity in the 4th quarter worth approximately $50,000. Finally, Huntington National Bank grew its position in shares of Doximity by 1,440.8% in the 4th quarter. Huntington National Bank now owns 1,094 shares of the company's stock worth $58,000 after buying an additional 1,023 shares during the last quarter. 87.19% of the stock is currently owned by institutional investors.

Insider Activity at Doximity

In related news, Director Kira Scherer Wampler sold 2,000 shares of the company's stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $56.93, for a total transaction of $113,860.00. Following the completion of the sale, the director now owns 16,618 shares in the company, valued at approximately $946,062.74. This represents a 10.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Anna Bryson sold 45,000 shares of the business's stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $57.23, for a total value of $2,575,350.00. Following the sale, the chief financial officer now directly owns 357,165 shares of the company's stock, valued at $20,440,552.95. This represents a 11.19% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 51,000 shares of company stock worth $2,900,770. 37.40% of the stock is owned by insiders.

Doximity Stock Performance

Shares of DOCS stock traded up $0.11 during mid-day trading on Monday, hitting $56.03. The company's stock had a trading volume of 1,414,492 shares, compared to its average volume of 2,138,183. Doximity, Inc. has a 52-week low of $25.00 and a 52-week high of $85.21. The business has a 50-day moving average price of $55.24 and a 200 day moving average price of $58.52. The stock has a market cap of $10.52 billion, a price-to-earnings ratio of 56.03, a PEG ratio of 4.10 and a beta of 1.32.

Doximity (NASDAQ:DOCS - Get Free Report) last posted its quarterly earnings results on Thursday, May 15th. The company reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.11. Doximity had a return on equity of 21.75% and a net margin of 36.60%. The firm's revenue for the quarter was up 17.1% compared to the same quarter last year. During the same period in the previous year, the company earned $0.25 earnings per share. Equities research analysts predict that Doximity, Inc. will post 0.99 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. Raymond James cut their price objective on Doximity from $83.00 to $65.00 and set an "outperform" rating on the stock in a research report on Friday, May 16th. Needham & Company LLC dropped their price target on Doximity from $82.00 to $67.00 and set a "buy" rating on the stock in a research report on Friday, May 16th. JPMorgan Chase & Co. dropped their price target on Doximity from $63.00 to $60.00 and set a "neutral" rating on the stock in a research report on Tuesday, May 27th. Robert W. Baird dropped their price target on Doximity from $87.00 to $65.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 20th. Finally, BTIG Research upgraded Doximity from a "neutral" rating to a "buy" rating and set a $80.00 price target on the stock in a research report on Monday, June 2nd. Eleven equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $62.84.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.